Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2013
03/13/2013CN102971291A Novel amide derivative and use thereof as medicine
03/13/2013CN102971290A Cationic 6-aminoindolines, dyeing compositions containing them, processes and uses thereof
03/13/2013CN102964338A Compound having triazole ring structure substituted with pyridyl group and organic electroluminescent device
03/13/2013CN102964337A Production method of high-optical-purity esomeprazole
03/13/2013CN102964336A Refining method of proton pump inhibitor and reducing method of N-oxide of proton pump inhibitor
03/13/2013CN102964335A Esomeprazole sodium compound and preparation method and applications thereof
03/13/2013CN102964294A Pyridyl inhibitors of hedgehog signalling
03/13/2013CN102964232A Preparation method of ketone compound and its derivatives
03/13/2013CN102180866B New crystal form of lansoprazole and preparation method and application thereof
03/13/2013CN102119029B 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands
03/13/2013CN102070605B Imatinib mesylate polymorph and pharmaceutical composition
03/13/2013CN101626685B N-substituted glycine derivatives: hydroxylase inhibitors
03/13/2013CN101544630B Preparation method of hydroxylated indinavir
03/13/2013CN101277948B Chemical process
03/13/2013CN101094848B Organic compounds
03/12/2013US8394963 Process for the preparation of esomeprazole magnesium dihydrate
03/12/2013US8394962 Method for the preparation of dabigatran and its intermediates
03/12/2013US8394961 Method for the preparation of dabigatran
03/12/2013US8394960 Thiazole carboxamide derivatives and their use to treat cancer
03/12/2013US8394952 Dihydrodiazepines useful as inhibitors of protein kinases
03/12/2013US8394838 Process for producing amide compound
03/12/2013US8394836 Indoles and their therapeutic use
03/12/2013US8394834 Pyrrolidines as NK3 receptor antagonists
03/12/2013US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
03/12/2013US8394828 Quinoline-derived amide modulators of vanilloid VR1 receptor
03/12/2013US8394807 Quinazoline inhibitors of BACE 1 and methods of using
03/12/2013US8394806 2-phenyl pyrazines as tubulin inhibitors
03/12/2013US8394803 Gyrase inhibitors and uses thereof
03/12/2013CA2731773C Amidophenoxyindazoles useful as inhibitors of c-met
03/12/2013CA2697551C Piperidine derivatives as modulators of gpr119 activity
03/12/2013CA2695088C Novel piperazine amide derivatives
03/12/2013CA2640534C 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
03/12/2013CA2637933C Indole sulfonamide modulators of progesterone receptors
03/12/2013CA2569763C 2,4-diaminoquinazolines for spinal muscular atrophy
03/12/2013CA2558051C Palladium catalyzed indolization of 2-bromo or chloroanilines
03/12/2013CA2551227C Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
03/12/2013CA2550350C 2-(hetero)aryl-substituted tetrahydroquinoline derivatives
03/12/2013CA2537936C Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
03/12/2013CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/07/2013WO2013033269A1 Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
03/07/2013WO2013033085A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
03/07/2013WO2013032960A2 Vitamin d receptor - coregulator inhibitors
03/07/2013WO2013032668A2 Anatabine-enriched tobacco products
03/07/2013WO2013032591A1 Heterocyclic compounds and uses thereof
03/07/2013WO2013032297A1 Benzocarbazole compounds and electroluminescent devices involving them
03/07/2013WO2013032035A1 Process for producing n-(hetero)arylazoles
03/07/2013WO2013031930A1 Imine derivative
03/07/2013WO2013031922A1 Pyrazole compound and use thereof for medical purposes
03/07/2013WO2013031794A1 Organic electroluminescence element, display device, and illumination device
03/07/2013WO2013031671A1 Method for producing pest controlling agent
03/07/2013WO2013030665A1 Pyrimidines as sodium channel blockers
03/07/2013WO2013030374A1 Novel crystal form
03/07/2013WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7
03/07/2013WO2013030100A1 Method for producing tetrazole-substituted anthranilic acid diamide derivatives by reacting benzoxazinones with amines
03/07/2013WO2013029431A1 Benzodiazepine derivatives tosylate salts, their polymorphic forms, preparation methods and uses thereof
03/07/2013WO2013029237A1 Double-center bipyridyl cationic ion liquid, preparation method therefor and use thereof
03/07/2013WO2012177678A3 Isotopologues of pomalidomide
03/07/2013WO2012117000A8 3-amino-pyridines as gpbar1 agonists
03/07/2013WO2012028332A8 Pharmaceutically active compounds as axl inhibitors
03/07/2013US20130060041 Synthesis of substituted pyrazoline carboxamidine derivatives
03/07/2013US20130060040 Salt and Crystalline Forms Thereof of a Drug
03/07/2013US20130060029 Quinazolinone derivatives useful as vanilloid antagonists
03/07/2013US20130060027 Tetrahydroisoquinolines and intermediates therefor
03/07/2013US20130060026 Processes and intermediates for making a jak inhibitor
03/07/2013US20130060025 Certain heterocycles, compositions thereof, and methods for their use
03/07/2013US20130059892 Compositions and Methods for Cancer Detection and Treatment
03/07/2013US20130059891 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof
03/07/2013US20130059889 Anhydrous lenalidomide form-i
03/07/2013US20130059887 Substituted pyridoxine-lactam carboxylate salts
03/07/2013US20130059879 Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics
03/07/2013US20130059874 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof
03/07/2013US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
03/07/2013US20130059872 Polymorphs of alogliptin benzoate
03/07/2013US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
03/07/2013US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
03/07/2013US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators
03/07/2013US20130059856 Agonists of gpr131 and uses thereof
03/07/2013US20130059855 Crystal of di(arylamino)aryl compound
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/07/2013US20130059838 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof
03/07/2013US20130059833 Pde10 modulators
03/07/2013US20130059830 Novel prolylcarboxypeptidase inhibitors
03/07/2013US20130059392 Aggregation-induced emission luminogens for metal ion detection
03/07/2013US20130056722 Novel organic compound
03/07/2013US20130056720 Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode
03/07/2013CA2847199A1 Products for anti-inflammation support
03/07/2013CA2847119A1 Process for producing n-(hetero)arylazoles
03/07/2013CA2847066A1 Novel crystal form
03/07/2013CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7
03/07/2013CA2846463A1 Pyrimidines as sodium channel blockers
03/07/2013CA2846431A1 Heterocyclic compounds and uses thereof
03/07/2013CA2845127A1 Pyrazole compound and pharmaceutical use thereof
03/07/2013CA2844916A1 Method for producing pest control agent
03/07/2013CA2844521A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
03/07/2013CA2844128A1 Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
03/06/2013EP2565191A1 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
03/06/2013EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7
03/06/2013EP2565185A1 [5,6]heterocyclic compound
03/06/2013EP2565184A1 Therapeutic agent and preventative agent for alzheimer's disease
03/06/2013EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
1 ... 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 ... 1080